Nisha Nanda
Director/Board Member bei MORPHIC HOLDING, INC.
Vermögen: - $ am 31.03.2024
Profil
Nisha Nanda is an Independent Director at Morphic Holding, Inc. She previously worked as a Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014.
She then served as the Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023.
Dr. Nanda holds undergraduate and doctorate degrees from The University of New South Wales.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MORPHIC HOLDING, INC.
-.--% | 01.04.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Nisha Nanda
Unternehmen | Position | Beginn |
---|---|---|
MORPHIC HOLDING, INC. | Director/Board Member | 19.08.2021 |
Ehemalige bekannte Positionen von Nisha Nanda
Unternehmen | Position | Ende |
---|---|---|
LOXO ONCOLOGY INC | Corporate Officer/Principal | 01.05.2023 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Nisha Nanda
The University of New South Wales | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MORPHIC HOLDING, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |